Deals
STERIS Lines Up $1.6 Billion Revolver And A $500 Million Loan Reserved For Xodus Deal
The new revolver replaces a 2024 facility, while the term loan can be drawn only if the Xodus Medical acquisition closes.
STE
STERIS (STE) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
Earnings
STERIS Lifts Fiscal 2027 Earnings Outlook To $11.35-$11.55 A Share As Life Sciences Revenue Jumps 18%
The sterilization company's new range includes about $0.18 a share from tariff refunds, while one segment's growth outlook was trimmed.
Deals
STERIS Agrees To Buy Xodus Medical For $2.1 Billion In Cash, With Up To $150 Million Earnout
The deal is financed mainly with debt, backed by a $2.0 billion bridge facility, and is anticipated to close by December 31, 2026.